FDA approves first generic Epipen

The FDA this week approved the first generic version of Mylan‘s (NSDQ:MYL) Epipen emergency allergy auto-injector.

Teva Pharmaceuticals (NYSE:TEVA), which won the historic approval, plans to market the generic epinephrine auto-injector in 0.3mg and 0.15mg doses. There are other epinephrine auto-injectors on the market in the U.S., but Teva’s is the first that’s approved to directly substitute the Epipen.

Get the full story at our sister site, Drug Delivery Business News.

The post FDA approves first generic Epipen appeared first on MassDevice.

from MassDevice https://ift.tt/2L2b4bi